Detalhe da pesquisa
1.
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy.
AIDS Res Ther
; 19(1): 24, 2022 06 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35672853